Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-04-25 7:02 pm Unchanged | 13D | CRINETICS PHARMACEUTICALS INC CRNX | PERCEPTIVE ADVISORS LLC | 5,333,532 10% | 0 (Unchanged) | View |
| 2022-04-20 9:17 pm Purchase | 13D | CRINETICS PHARMACEUTICALS INC CRNX | PERCEPTIVE ADVISORS LLC | 5,333,532 10% | 1,674,151 (+45.75%) | View |
| 2022-02-14 09:08 am Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Deep Track Capital LP | 1,900,000 4% | 1,334 (+0.07%) | View |
| 2022-02-11 5:22 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Vivo Capital VIII LLC | 0 0% | -1,819,600 (Position Closed) | View |
| 2022-02-11 4:19 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | ORBIMED ADVISORS LLC | 3,196,876 6.7% | 443,309 (+16.10%) | View |
| 2022-02-10 8:21 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Versant Venture Capital V L.P. | 382,961 0.8% | -1,512,041 (-79.79%) | View |
| 2022-02-10 4:30 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Struthers Richard Scott | 1,978,334 4.2% | 274,339 (+16.10%) | View |
| 2022-02-03 4:41 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BlackRock Inc. BLK | 3,276,170 6.9% | 1,162,975 (+55.03%) | View |
| 2022-01-10 1:26 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 3,722,294 7.836% | -1,216,055 (-24.62%) | View |
| 2022-01-10 11:09 am Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | DRIEHAUS CAPITAL MANAGEMENT LLC | 4,793,638 10.09% | 4,793,638 (New Position) | View |
| 2021-10-29 4:29 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BIOTECHNOLOGY VALUE FUND L P | 3,003,879 6.5% | 3,003,879 (New Position) | View |
| 2021-04-22 5:56 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Deep Track Capital LP | 1,898,666 5.05% | 1,898,666 (New Position) | View |
| 2021-02-16 4:39 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | RA CAPITAL MANAGEMENT L.P. | 564,102 1.7% | -1,311,107 (-69.92%) | View |
| 2021-02-16 06:31 am Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | 5AM Ventures IV L.P. | 1,362,286 4.1% | -1,000,000 (-42.33%) | View |
| 2021-02-12 8:27 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Versant Venture Capital V L.P. | 1,895,002 5.8% | -789,560 (-29.41%) | View |
| 2021-02-12 4:44 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | ORBIMED ADVISORS LLC | 2,753,567 8.36% | 714,285 (+35.03%) | View |
| 2021-02-12 4:30 pm Sale | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Vivo Capital VIII LLC | 1,819,600 5.5% | -425,304 (-18.95%) | View |
| 2021-02-08 10:19 am Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | FMR LLC | 4,938,349 14.999% | 1,305,018 (+35.92%) | View |
| 2021-02-05 4:21 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | Struthers Richard Scott | 1,703,995 5.1% | 200,841 (+13.36%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | CRINETICS PHARMACEUTICALS INC CRNX | BlackRock Inc. BLK | 2,113,195 6.4% | 2,113,195 (New Position) | View |